Oklahoma 2025 Regular Session

Oklahoma House Bill HB1714 Latest Draft

Bill / Introduced Version Filed 01/16/2025

                             
 
Req. No. 11190 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 60th Legislature (2025) 
 
HOUSE BILL 1714 	By: Bennett 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to employment of individuals who 
lawfully consume cannabis; defining term; providing 
protection for employment; providin g for 
codification; and providing an effective date . 
 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 427.28a of Title 63, unless 
there is created a duplication in numbering, reads as follows: 
A.  For the purposes of this section, "cannabis" means all parts 
of the plant Cannabis sativa L., whether growing or not; the seeds 
thereof; the resin extracted from any part of such pla nt; and every 
compound, manufacture, salt, derivative, mixture or preparation of 
such plant, its seeds or resin, but shall not include: 
1.  The mature stalks of such plant or fiber produced from such 
stalks; 
2.  Oil or cake made from the seeds of such plan t, including 
cannabidiol derived from the seeds of the marijuana plant;   
 
Req. No. 11190 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  Any other compound, manufacture, salt, derivative, mixture 
or preparation of such mature stalks (except the resin extracted 
therefrom), including cannabidiol derived from mature st alks, fiber, 
oil or cake; 
4.  The sterilized seed of such plant which is incapable of 
germination; 
5.  For any person participating in a clinical trial to 
administer cannabidiol for the treatment of severe forms of epilepsy 
pursuant to Section 2-802 of Title 63 of the Oklahoma Statutes , a 
drug or substance approved by the federal Fo od and Drug 
Administration for use by those participants; 
6.  For any person or the parents, legal guardians or caretakers 
of the person who have received a written certification from a 
physician licensed in this state that the person has been diagnosed 
by a physician as having Lennox -Gastaut syndrome, Dravet syndrome, 
also known as severe myoclonic epilepsy of infancy, or any other 
severe form of epilepsy that is not adequately t reated by 
traditional medical therapies, spasticity due to multiple sclerosis 
or due to paraplegia, intractable nausea and vomiting, appetite 
stimulation with chronic wasting diseases, the substance 
cannabidiol, a nonpsychoactive cannabinoid, found in the plant 
Cannabis sativa L. or any other preparation thereof, that has a 
tetrahydrocannabinol concentration not more than three -tenths of one   
 
Req. No. 11190 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
percent (0.3%) and that is delivered to the patient in the form of a 
liquid; 
7.  Any federal Food and Drug Administra tion-approved drug or 
substance; or 
8.  Industrial hemp, from the plant Cannab is sativa L. and any 
part of such plant, whether growing or not, with a delta -9 
tetrahydrocannabinol concentration not more than three -tenths of one 
percent (0.3%) on a dry -weight basis which shall only be grown 
pursuant to the Oklahoma Industrial Hemp Program and may be shipped 
intrastate and interstate. 
B.  It is unlawful for an employer to discriminate against a 
person in the initial hiring for employment if the discrimination is 
based upon: 
1.  The person's use of cannabis off the job and away from the 
workplace; or 
2.  An employer-required drug screening test that has found the 
person to have nonpsychoactive cannabis metabolites in his or her 
hair, blood, urine, or other bodil y fluids. 
C.  Nothing in this subsection: 
1.  Prohibits an employer from basing initial hiring decisions 
on scientifically valid drug screening conducted through methods 
that do not screen for nonpsychoactive cannabis metabolites;   
 
Req. No. 11190 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  Affects the rights or obligations of an employer to maintain 
a drug- and alcohol-free workplace, or any other rights or 
obligations of an employer required by federal law or regulation; or 
3.  Applies to testing for controlled substances other than 
preemployment, such as post -accident testing or testing because of a 
suspicion of impairment or being under the influence of alcohol, 
controlled substances, medications, or other substances. 
D.  This section does not apply to an applicant applying for a 
position that requires a feder al government background investigation 
or security clearance or in the airline or aerospace industries, or 
any other safety sensitive position for which impairment while 
working presents a substantial risk of death.  Such safety sensitive 
positions shall be identified by the employer prior to the 
applicant's application for employment. 
E.  1.  This section does not preempt state or federal laws 
requiring an applicant to be tested for controlled substances. This 
includes state or federal laws requiring appl icants to be tested, or 
the way they are tested, as a condition of employment, receiving 
federal funding or federal licensing -related benefits, or as 
required by a federal contract. 
2.  Employers may require an applicant to be tested for a 
spectrum of controlled substances, which may include cannabis, as 
long as the cannabis results are not provided to the employer. Such 
policies are fully subject to subsection B of this section.   
 
Req. No. 11190 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
SECTION 2.  This act shall become effective November 1, 2025. 
 
60-1-11190 TJ 01/07/25